Metabolomic study of cisplatin-induced nephrotoxicity. (Q53624595)

16 May 2018

title

Metabolomic study of cisplatin-induced nephrotoxicity. (English)

1 reference

16 May 2018

author name string

Portilla D

1

1 reference

16 May 2018

Li S

2

1 reference

16 May 2018

Nagothu KK

3

1 reference

16 May 2018

Megyesi J

4

1 reference

16 May 2018

Kaissling B

5

1 reference

16 May 2018

Schnackenberg L

6

1 reference

16 May 2018

Safirstein RL

7

1 reference

16 May 2018

Beger RD

8

1 reference

16 May 2018

language of work or name

English

0 references

publication date

3 May 2006

1 reference

16 May 2018

published in

Kidney International

1 reference

16 May 2018

volume

69

1 reference

16 May 2018

page(s)

2194-2204

1 reference

16 May 2018

issue

12

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000433

exact match

0 references

cites work

Role of insulin in glucose intolerance in uraemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

The site of insulin resistance in acute uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Muscle protein turnover and glucose uptake in acutely uremic rats. Effects of insulin and the duration of renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Clinical and metabolic responses to parenteral nutrition in acute renal failure. A controlled double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Influence of Extracorporeal Dialysis on Glucose Utilization and Insulin Secretion in Patients with Acute Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Hypoxia-induced amphiphiles inhibit renal Na+, K(+)-ATPase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Recent advances in the pathophysiology of ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Plasmalogen phospholipid hydrolysis during hypoxic injury of rabbit proximal tubules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Role of cytosolic calcium-independent plasmalogen-selective phospholipase A2 in hypoxic injury to rabbit proximal tubules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Role of fatty acid beta-oxidation and calcium-independent phospholipase A2 in ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Triglyceride accumulation in injured renal tubular cells: alterations in both synthetic and catabolic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Energy metabolism and cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

PPARα ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Fibrate prevents cisplatin-induced proximal tubule cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

1H NMR Pattern Recognition and 31P NMR Studies with d-Serine in Rat Urine and Kidney, Time- and Dose-Related Metabolic Effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Regulation of renal amino acid (AA) transport by hormones, drugs and xenobiotics - a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Renal amino acid transport in immature and adult rats during chromate and cisplatinum-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Aminoglycoside antibiotics reduce glucose reabsorption in kidney through down-regulation of SGLT1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Glucose intolerance following cis-platinum treatment in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Bezafibrate, a peroxisome proliferator-activated receptor (PPAR)-alpha activator, prevents pancreatic degeneration in obese and diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Pancreatic islet response to hyperglycemia is dependent on peroxisome proliferator-activated receptor alpha (PPARalpha).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Hyperlipidaemia in cisplatin-induced nephrotic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000433

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000433

1 reference

16 May 2018

PubMed ID

16672910

1 reference

16 May 2018